Lentiviral Vectors CDMO Solution

Hillgene offers end-to-end lentivirus CDMO services for lentiviral vector production, providing high-quality, scalable, and regulatory-compliant solutions for cell and gene therapy developers, from initial plasmid design and vector construction to GMP-grade manufacturing and rigorous quality control testing. With extensive experience in lentivirus production and a strong focus on viral safety and consistency, Hillgene ensures rapid timelines and flexible batch sizes. We specialize in both research-grade and clinical-grade lentiviral vectors tailored to client needs. Our state-of-the-art facilities are equipped to support CAR-T, CAR-NK, and other cell therapy applications. As a trusted lentiviral vector CDMO partner, Hillgene follows strict GMP guidelines and global regulatory standards. Partner with Hillgene to accelerate your gene therapy pipeline with reliable, scalable, and cost-effective lentiviral vector manufacturing services.